Gliclazide Pellets

Gliclazide PelletsGliclazide is an oral hypoglycemic (anti-diabetic drug) and is classified as a sulfonylurea. A modified-release formulation is also marketed.

Its classification has been ambiguous, as literature uses it as both a first-generation and second-generation sulfonylurea.

Available Form:
Gliclazide Pellets
Gliclazide Granules

Umang Pharmatech equipments used for production of Gliclazide Pellets:
Drug Layering, Fluid Bed Dryer, Fluid Bed Coater, Sifter & Blender, Extruder and Twin spheronizer.

Gliclazide Pellets
Systematic (IUPAC) Name
Gliclazide Pellets
Identifiers
Gliclazide Pellets
Chemical data
N-(hexahydrocyclopenta[c]pyrrol-2(1H)-ylcarbamoyl)-4-methylbenzenesulfonamide
CAS number : 21187-98-4
ATC code : A10BB09
PubChem : CID 3475
DrugBank : APRD00460
ChemSpider : 3356
UNII : G4PX8C4HKV
KEGG : D01599
ChEMBL : CHEMBL427216
Formula : C15H21N3O3S
Mol. mass : 323.412 gmol


* All transactions are carried out in conformity with patent laws applicable in the user country. Active pharmaceutical ingredients or formulations thereof will not be supplied in countries where the same is under patent protection except as and if permitted under law of the country for research and development purposes only.
Extruder Spheronizer Email Us Umang Pharmatech
TESTIMONIAL